Alpharetta-based ModifyHealth has closed a $2 million Series A funding round led by Nashville Capital Network.
The company provides meal delivery, dietician support and digital health services for patients suffering from chronic gastrointestinal diseases like irritable bowel syndrome and celiac disease. It was founded in 2018.
The partnership will support continued product and service growth and expansion of nationwide operations.
For diseases like IBS, inflammatory bowel disease and small intestinal bacterial overgrowth (SIBO) where physicians recommend dietary modification as part of treatment, ModifyHealth offers patients delivery of prepared organic, non-GMO meals and consultation with dieticians.
“We’re excited to partner with Nashville Capital Network and look forward to putting this new capital to work to support more customers,” G.B. Pratt, founder and CEO of ModifyHealth, said in the announcement. “There’s a growing recognition of the vital role ‘food as medicine’ will play in the management of chronic health conditions and we’re just scratching the surface on the impact we can make. NCN is a great cultural fit and their strategic support and healthcare expertise will help us execute our vision even more rapidly and broadly.”
Nashville Capital Network Managing Partner Chase Perry will join ModifyHealth's board of directors.
“ModifyHealth is a perfect fit for NCN and our investor partnership,” Perry said in the announcement. “The ModifyHealth team has delivered rapid growth on a national scale and we look forward to supporting the company’s market leadership and next chapter of growth.”
The Series A funding announced Aug. 7 comes after ModifyHealth raises a $2 million seed round in early 2019.
Founded in 2003, Nashville Capital Network (NCN) is a partnership of more than 100 professional investors –– most of whom have been founders and executives of highly successful businesses — that provides growth capital for early stage companies. It manages more than $75 million in capital. NCN is currently investing out of its fourth fund, NCN Partners Fund.
